| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |